{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T16:39:20Z","timestamp":1770827960765,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Cardiol"],"DOI":"10.1007\/s00246-026-04186-3","type":"journal-article","created":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:59:18Z","timestamp":1770825558000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Predicting the Need for Infliximab in Kawasaki Disease Using N-Terminal Pro-Brain Natriuretic Peptide at Diagnosis"],"prefix":"10.1007","author":[{"given":"Shin-ichiro","family":"Hori","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoji","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Mine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiro","family":"Kino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Araki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunari","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,11]]},"reference":[{"key":"4186_CR1","doi-asserted-by":"publisher","first-page":"e2216642","DOI":"10.1001\/jamanetworkopen.2022.16642","volume":"5","author":"N Takekoshi","year":"2022","unstructured":"Takekoshi N, Kitano N, Takeuchi T, Suenaga T, Kakimoto N, Suzuki T, Kada TT, Shibuta S, Tachibana S, Murayama Y, Yamaga H, Suzuki H (2022) Analysis of Age, Sex, lack of response to intravenous Immunoglobulin, and development of coronary artery abnormalities in children with Kawasaki disease in Japan. JAMA Netw Open 5:e2216642. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.16642","journal-title":"JAMA Netw Open"},{"key":"4186_CR2","doi-asserted-by":"publisher","first-page":"e481","DOI":"10.1161\/CIR.0000000000001295","volume":"150","author":"PN Jone","year":"2024","unstructured":"Jone PN, Tremoulet A, Choueiter N, Dominguez SR, Harahsheh AS, Mitani Y, Zimmerman M, Lin MT, Friedman KG, American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Lifelong Congenital Heart Disease and heart health in the Young; Council on cardiovascular and stroke Nursing; Council on cardiovascular radiology and Intervention; and Council on clinical cardiology (2024) update on diagnosis and management of Kawasaki disease: a scientific statement from the American heart association. Circulation 150:e481\u2013e500 https:\/\/doi.org\/10.1161\/CIR.0000000000001313","journal-title":"Circulation"},{"key":"4186_CR3","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/s0140-6736(84)91504-6","volume":"2","author":"K Furusho","year":"1984","unstructured":"Furusho K, Kamiya T, Nakano H et al (1984) High-dose intravenous gammaglobulin for Kawasaki disease. Lancet 2:1055\u20131058. https:\/\/doi.org\/10.1016\/s0140-6736(84)91504-6","journal-title":"Lancet"},{"key":"4186_CR4","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1056\/NEJM199106063242305","volume":"324","author":"JW Newburger","year":"1991","unstructured":"Newburger JW, Takahashi M, Beiser AS et al (1991) A single intravenous infusion of gamma Globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med 324:1633\u20131639. https:\/\/doi.org\/10.1056\/NEJM199106063242305","journal-title":"N Engl J Med"},{"key":"4186_CR5","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1007\/s00431-017-2937-5","volume":"176","author":"SM Dietz","year":"2017","unstructured":"Dietz SM, van Stijn D, Burgner D, Levin M, Kuipers IM, Hutten BA, Kuijpers TW (2017) Dissecting Kawasaki disease: a state-of-the-art review. Eur J Pediatr 176:995\u20131009. https:\/\/doi.org\/10.1007\/s00431-017-2937-5","journal-title":"Eur J Pediatr"},{"key":"4186_CR6","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1007\/s10067-023-06502-1","volume":"42","author":"Y Sunaga","year":"2023","unstructured":"Sunaga Y, Watanabe A, Katsumata N, Toda T, Yoshizawa M, Kono Y, Hasebe Y, Koizumi K, Hoshiai M, Kawakami E, Inukai T (2023) A simple scoring model based on machine learning predicts intravenous Immunoglobulin resistance in Kawasaki disease. Clin Rheumatol 42:1351\u20131361. https:\/\/doi.org\/10.1007\/s10067-023-06502-1","journal-title":"Clin Rheumatol"},{"key":"4186_CR7","doi-asserted-by":"publisher","first-page":"969502","DOI":"10.3389\/fped.2022.969502","volume":"10","author":"C Liu","year":"2022","unstructured":"Liu C, Wu J (2022) Value of blood inflammatory markers for predicting intravenous Immunoglobulin resistance in Kawasaki disease: A systematic review and meta-analysis. Front Pediatr 10:969502. https:\/\/doi.org\/10.3389\/fped.2022.969502","journal-title":"Front Pediatr"},{"key":"4186_CR8","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1161\/CIRCULATIONAHA.105.592865","volume":"113","author":"T Kobayashi","year":"2006","unstructured":"Kobayashi T, Inoue Y, Takeuchi K, Okada Y, Tamura K, Tomomasa T, Kobayashi T, Morikawa A (2006) Prediction of intravenous Immunoglobulin unresponsiveness in patients with Kawasaki disease. Circulation 113:2606\u20132612. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.105.592865","journal-title":"Circulation"},{"key":"4186_CR9","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jpeds.2006.03.050","volume":"149","author":"K Egami","year":"2006","unstructured":"Egami K, Muta H, Ishii M, Suda K, Sugahara Y, Iemura M, Matsuishi T (2006) Prediction of resistance to intravenous Immunoglobulin treatment in patients with Kawasaki disease. J Pediatr 149:237\u2013240. https:\/\/doi.org\/10.1016\/j.jpeds.2006.03.050","journal-title":"J Pediatr"},{"key":"4186_CR10","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s00431-006-0223-z","volume":"166","author":"T Sano","year":"2007","unstructured":"Sano T, Kurotobi S, Matsuzaki K, Yamamoto T, Maki I, Miki K, Kogaki S, Hara J (2007) Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment. Eur J Pediatr 166:131\u2013137. https:\/\/doi.org\/10.1007\/s00431-006-0223-z","journal-title":"Eur J Pediatr"},{"issue":"1","key":"4186_CR11","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1038\/s41598-017-18387-7","volume":"8","author":"M Mori","year":"2018","unstructured":"Mori M, Hara T, Kikuchi M, Shimizu H, Miyamoto T, Iwashima S, Oonishi T, Hashimoto K, Kobayashi N, Waki K, Suzuki Y, Otsubo Y, Yamada H, Ishikawa C, Kato T, Fuse S (2018) Infliximab versus intravenous Immunoglobulin for refractory Kawasaki disease: a phase 3, randomized, open-label, active-controlled, parallel-group, multicenter trial. Sci Rep 8(1):1994 https:\/\/doi.org\/10.1038\/s41598-017-18387-7","journal-title":"Sci Rep"},{"key":"4186_CR12","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/bcp.15547","volume":"89","author":"S Kabbaha","year":"2023","unstructured":"Kabbaha S, Milano A, Aldeyab MA, Thorlund K (2023) Infliximab as a second-line therapy for children with refractory Kawasaki disease: A systematic review and meta-analysis of randomized controlled trials. Br J Clin Pharmacol 89:49\u201360. https:\/\/doi.org\/10.1111\/bcp.15547","journal-title":"Br J Clin Pharmacol"},{"key":"4186_CR13","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1007\/s00431-024-05437-2","volume":"183","author":"L Wang","year":"2024","unstructured":"Wang L, He M, Wang W, Li S, Zhao G (2024) Efficacy and safety of Infliximab in the treatment of Kawasaki disease: A systematic review and meta-analysis. Eur J Pediatr 183:1765\u20131776. https:\/\/doi.org\/10.1007\/s00431-024-05437-2","journal-title":"Eur J Pediatr"},{"key":"4186_CR14","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.pedhc.2016.07.009","volume":"31","author":"K Williams","year":"2017","unstructured":"Williams K (2017) Preventing Long-Term cardiac damage in pediatric patients with Kawasaki disease. J Pediatr Health Care 31:196\u2013202. https:\/\/doi.org\/10.1016\/j.pedhc.2016.07.009","journal-title":"J Pediatr Health Care"},{"key":"4186_CR15","doi-asserted-by":"publisher","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","volume":"79","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, Deswal A, Drazner MH, Dunlay SM, Evers LR, Fang JC, Fedson SE, Fonarow GC, Hayek SS, Hernandez AF, Khazanie P, Kittleson MM, Lee CS, Link MS, Milano CA, Nnacheta LC, Sandhu AT, Stevenson LW, Vardeny O, Vest AR, Yancy CW (2022) 2022 AHA\/ACC\/HFSA guideline for the management of heart failure: A report of the American college of Cardiology\/American heart association joint committee on clinical practice guidelines. J Am Coll Cardiol 79:e263\u2013e421. https:\/\/doi.org\/10.1016\/j.jacc.2021.12.012","journal-title":"J Am Coll Cardiol"},{"key":"4186_CR16","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.cardfail.2023.02.009","volume":"29","author":"H Tsutsui","year":"2023","unstructured":"Tsutsui H, Albert NM, Coats AJS, Anker SD, Bayes-Genis A, Butler J, Chioncel O, Defilippi CR, Drazner MH, Felker GM, Filippatos G, Fiuzat M, Ide T, Januzzi JL Jr., Kinugawa K, Kuwahara K, Matsue Y, Mentz RJ, Metra M, Pandey A, Rosano G, Saito Y, Sakata Y, Sato N, Seferovic PM, Teerlink J, Yamamoto K, Yoshimura M (2023) Natriuretic peptides: role in the diagnosis and management of heart failure: A scientific statement from the heart failure association of the European society of Cardiology, heart failure society of America and Japanese heart failure society. J Card Fail 29:787\u2013804. https:\/\/doi.org\/10.1016\/j.cardfail.2023.02.009","journal-title":"J Card Fail"},{"key":"4186_CR17","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1007\/s00246-011-9986-8","volume":"32","author":"K Kaneko","year":"2011","unstructured":"Kaneko K, Yoshimura K, Ohashi A, Kimata T, Shimo T, Tsuji S (2011) Prediction of the risk of coronary arterial lesions in Kawasaki disease by brain natriuretic peptide. Pediatr Cardiol 32:1106\u20131109. https:\/\/doi.org\/10.1007\/s00246-011-9986-8","journal-title":"Pediatr Cardiol"},{"key":"4186_CR18","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/j.jpeds.2012.11.026","volume":"162","author":"K Yoshimura","year":"2013","unstructured":"Yoshimura K, Kimata T, Mine K, Uchiyama T, Tsuji S, Kaneko K (2013) N-terminal pro-brain natriuretic peptide and risk of coronary artery lesions and resistance to intravenous Immunoglobulin in Kawasaki disease. J Pediatr 162:1205\u20131209. https:\/\/doi.org\/10.1016\/j.jpeds.2012.11.026","journal-title":"J Pediatr"},{"key":"4186_CR19","doi-asserted-by":"publisher","first-page":"e0248812","DOI":"10.1371\/journal.pone.0248812","volume":"16","author":"X Zheng","year":"2021","unstructured":"Zheng X, Li J, Yue P, Liu L, Li J, Zhou K, Hua Y, Li Y (2021) Is there an association between intravenous Immunoglobulin resistance and coronary artery lesion in Kawasaki disease?-Current evidence based on a meta-analysis. PLoS ONE 16:e0248812. https:\/\/doi.org\/10.1371\/journal.pone.0248812","journal-title":"PLoS ONE"},{"key":"4186_CR20","first-page":"41","volume":"5","author":"M Miura","year":"2021","unstructured":"Miura M, Ayusawa M, Fukazawa R, Hamada H, Ikeda S, Ito S, Kanai T, Kobayashi T, Suzuki H, Yamamura K, Miyata K, Yokoyama U, Ichida F, Mitani Y, Terai M (2021) Guidelines for medical treatment of acute Kawasaki disease (2020 revised Version). J Pediatr Cardiol Card Surg 5:41\u201373","journal-title":"J Pediatr Cardiol Card Surg"},{"key":"4186_CR21","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/s0022-3476(78)80601-5","volume":"93","author":"GB Haycock","year":"1978","unstructured":"Haycock GB, Schwartz GJ, Wisotsky DH (1978) Geometric method for measuring body surface area: a height-weight formula validated in infants, children, and adults. J Pediatr 93:62\u201366. https:\/\/doi.org\/10.1016\/s0022-3476(78)80601-5","journal-title":"J Pediatr"},{"key":"4186_CR22","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1253\/circj.cj-12-1281","volume":"77","author":"M Shiraishi","year":"2013","unstructured":"Shiraishi M, Fuse S, Mori T, Doyama A, Honjyo S, Hoshino Y, Hoshino E, Kawaguchi A, Kuroiwa Y, Hotsubo T (2013) N-terminal pro-brain natriuretic peptide as a useful diagnostic marker of acute Kawasaki disease in children. Circ J 77:2097\u20132101. https:\/\/doi.org\/10.1253\/circj.cj-12-1281","journal-title":"Circ J"},{"key":"4186_CR23","doi-asserted-by":"publisher","first-page":"e70007","DOI":"10.1111\/ped.70007","volume":"67","author":"Y Nakamura","year":"2025","unstructured":"Nakamura Y, Yashiro M, Yanagawa H (2025) Epidemiology of Kawasaki disease in Japan in 2021\u20132022: results of the 27th nationwide survey. Pediatr Int 67:e70007. https:\/\/doi.org\/10.1111\/ped.70007","journal-title":"Pediatr Int"},{"key":"4186_CR24","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.ejheart.2003.12.015","volume":"6","author":"C Hall","year":"2004","unstructured":"Hall C (2004) Essential biochemistry and physiology of (NT-pro)BNP. Eur J Heart Fail 6:257\u2013260. https:\/\/doi.org\/10.1016\/j.ejheart.2003.12.015","journal-title":"Eur J Heart Fail"},{"key":"4186_CR25","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3390\/children5100141","volume":"5","author":"A Dionne","year":"2018","unstructured":"Dionne A, Dahdah N (2018) A decade of NT-proBNP in acute Kawasaki Disease, from physiological response to clinical relevance. Child (Basel) 5:141. https:\/\/doi.org\/10.3390\/children5100141","journal-title":"Child (Basel)"},{"key":"4186_CR26","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s12519-013-0402-8","volume":"9","author":"S Iwashima","year":"2013","unstructured":"Iwashima S, Ishikawa T (2013) B-type natriuretic peptide and N-terminal pro-BNP in the acute phase of Kawasaki disease. World J Pediatr 9:239\u2013244. https:\/\/doi.org\/10.1007\/s12519-013-0402-8","journal-title":"World J Pediatr"},{"key":"4186_CR27","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ijcard.2011.06.065","volume":"164","author":"YZ Sato","year":"2013","unstructured":"Sato YZ, Molkara DP, Daniels LB, Tremoulet AH, Shimizu C, Kanegaye JT, Best BM, Snider JV, Frazer JR, Maisel A, Burns JC (2013) Cardiovascular biomarkers in acute Kawasaki disease. Int J Cardiol 164:58\u201363. https:\/\/doi.org\/10.1016\/j.ijcard.2011.06.065","journal-title":"Int J Cardiol"},{"key":"4186_CR28","doi-asserted-by":"publisher","first-page":"e006703","DOI":"10.1136\/bmjopen-2014-006703","volume":"5","author":"KH Lin","year":"2015","unstructured":"Lin KH, Chang SS, Yu CW, Lin SC, Liu SC, Chao HY, Lee MT, Wu JY, Lee CC (2015) Usefulness of natriuretic peptide for the diagnosis of Kawasaki disease: a systematic review and meta-analysis. BMJ Open 5:e006703. https:\/\/doi.org\/10.1136\/bmjopen-2014-006703","journal-title":"BMJ Open"},{"key":"4186_CR29","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12969-017-0149-1","volume":"15","author":"T Xie","year":"2017","unstructured":"Xie T, Wang Y, Fu S, Wang W, Xie C, Zhang Y, Gong F (2017) Predictors for intravenous Immunoglobulin resistance and coronary artery lesions in Kawasaki disease. Pediatr Rheumatol Online J 15:17. https:\/\/doi.org\/10.1186\/s12969-017-0149-1","journal-title":"Pediatr Rheumatol Online J"},{"key":"4186_CR30","doi-asserted-by":"publisher","first-page":"1237670","DOI":"10.3389\/fimmu.2023.1237670","volume":"14","author":"J Chen","year":"2023","unstructured":"Chen J, Liao J, Xiang L, Zhang S, Yan Y (2023) Current knowledge of TNF-\u03b1 monoclonal antibody Infliximab in treating Kawasaki disease: a comprehensive review. Front Immunol 14:1237670. https:\/\/doi.org\/10.3389\/fimmu.2023.1237670","journal-title":"Front Immunol"},{"key":"4186_CR31","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jpeds.2017.10.013","volume":"195","author":"H Masuda","year":"2018","unstructured":"Masuda H, Kobayashi T, Hachiya A, Nakashima Y, Shimizu H, Nozawa T, Ogihara Y, Ito S, Takatsuki S, Katsumata N, Suzuki Y, Takenaka S, Hirono K, Kobayashi T, Suzuki H, Suganuma E, Takahashi K, Saji T, Committee of Survey on Infliximab use for Kawasaki disease (2018) Infliximab for the treatment of refractory Kawasaki disease: A nationwide survey in Japan. J Pediatr 195:115\u2013120e113. https:\/\/doi.org\/10.1016\/j.jpeds.2017.10.013","journal-title":"J Pediatr"},{"key":"4186_CR32","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1007\/s10875-012-9668-1","volume":"32","author":"HC Kuo","year":"2012","unstructured":"Kuo HC, Yang YL, Chuang JH, Tiao MM, Yu HR, Huang LT, Yang KD, Chang WC, Lee CP, Huang YH (2012) Inflammation-induced Hepcidin is associated with the development of anemia and coronary artery lesions in Kawasaki disease. J Clin Immunol 32:746\u2013752. https:\/\/doi.org\/10.1007\/s10875-012-9668-1","journal-title":"J Clin Immunol"},{"key":"4186_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12969-018-0303-4","volume":"17","author":"Y Li","year":"2019","unstructured":"Li Y, Zheng Q, Zou L, Wu J, Guo L, Teng L, Zheng R, Jung LKL, Lu M (2019) Kawasaki disease shock syndrome: clinical characteristics and possible use of IL-6, IL-10 and IFN-gamma as biomarkers for early recognition. Pediatr Rheumatol Online J 17:1. https:\/\/doi.org\/10.1186\/s12969-018-0303-4","journal-title":"Pediatr Rheumatol Online J"},{"key":"4186_CR34","doi-asserted-by":"publisher","first-page":"820","DOI":"10.3390\/ijms18040820","volume":"18","author":"YH Huang","year":"2017","unstructured":"Huang YH, Kuo HC (2017) Anemia in Kawasaki disease: Hepcidin as a potential biomarker. Int J Mol Sci 18:820. https:\/\/doi.org\/10.3390\/ijms18040820","journal-title":"Int J Mol Sci"}],"container-title":["Pediatric Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-026-04186-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00246-026-04186-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-026-04186-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:59:18Z","timestamp":1770825558000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00246-026-04186-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,11]]},"references-count":34,"alternative-id":["4186"],"URL":"https:\/\/doi.org\/10.1007\/s00246-026-04186-3","relation":{},"ISSN":["0172-0643","1432-1971"],"issn-type":[{"value":"0172-0643","type":"print"},{"value":"1432-1971","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,11]]},"assertion":[{"value":"3 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Institutional Review Board of Kansai Medical University Hospital (Approval No. 2024252).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}